UiPath Inc
NYSE:PATH
UiPath Inc
NYSE:PATH
Price:
11.905
USD
-1.29%
Market Cap:
$6.4B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
UiPath Inc
NYSE:PATH
|
US |
|
F
|
Focus Media Information Technology Co Ltd
SZSE:002027
|
CN |
|
C
|
Cardinal Health Inc
LSE:0HTG
|
US |
|
Beijing SinoHytec Co Ltd
SSE:688339
|
CN |
|
S
|
Sunshine Guojian Pharmaceutical Shanghai Co Ltd
SSE:688336
|
CN |
|
H
|
Hainan Poly Pharm Co Ltd
SZSE:300630
|
CN |
|
New Murchison Gold Ltd
ASX:NMG
|
AU |
|
Kaizen Discovery Inc
XTSX:KZD
|
CA |
Balance Sheet
Balance Sheet Decomposition
UiPath Inc
UiPath Inc
Balance Sheet Decomposition is not available for
UiPath Inc
UiPath Inc
Balance Sheet
UiPath Inc
UiPath Inc
Currency: USD
| Jan-2020 | Jan-2021 | Jan-2022 | Jan-2023 | Jan-2024 | Jan-2025 | Jan-2026 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
232
|
358
|
1 769
|
1 402
|
1 062
|
879
|
871
|
|
| Cash Equivalents |
232
|
358
|
1 769
|
1 402
|
1 062
|
879
|
871
|
|
| Short-Term Investments |
0
|
103
|
96
|
355
|
818
|
750
|
601
|
|
| Total Receivables |
118
|
218
|
337
|
444
|
520
|
540
|
581
|
|
| Accounts Receivables |
106
|
207
|
327
|
444
|
520
|
540
|
581
|
|
| Other Receivables |
12
|
11
|
10
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
50
|
56
|
75
|
144
|
180
|
169
|
191
|
|
| Total Current Assets |
401
|
734
|
2 277
|
2 344
|
2 580
|
2 339
|
2 244
|
|
| PP&E Net |
44
|
32
|
66
|
81
|
80
|
99
|
110
|
|
| PP&E Gross |
44
|
32
|
66
|
81
|
80
|
99
|
0
|
|
| Accumulated Depreciation |
10
|
18
|
22
|
28
|
33
|
40
|
0
|
|
| Intangible Assets |
17
|
18
|
20
|
31
|
19
|
10
|
20
|
|
| Goodwill |
25
|
28
|
54
|
88
|
89
|
87
|
125
|
|
| Note Receivable |
0
|
2
|
3
|
7
|
6
|
3
|
2
|
|
| Long-Term Investments |
0
|
0
|
20
|
3
|
0
|
119
|
217
|
|
| Other Long-Term Assets |
21
|
52
|
133
|
182
|
180
|
208
|
461
|
|
| Other Assets |
25
|
28
|
54
|
88
|
89
|
87
|
125
|
|
| Total Assets |
508
N/A
|
867
+71%
|
2 573
+197%
|
2 735
+6%
|
2 955
+8%
|
2 865
-3%
|
3 179
+11%
|
|
| Liabilities | ||||||||
| Accounts Payable |
5
|
7
|
12
|
9
|
3
|
33
|
10
|
|
| Accrued Liabilities |
78
|
131
|
165
|
186
|
172
|
147
|
292
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
156
|
228
|
351
|
432
|
536
|
618
|
604
|
|
| Total Current Liabilities |
239
|
365
|
528
|
627
|
712
|
799
|
905
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
4
|
0
|
|
| Other Liabilities |
73
|
83
|
123
|
189
|
227
|
217
|
191
|
|
| Total Liabilities |
311
N/A
|
448
+44%
|
651
+45%
|
815
+25%
|
939
+15%
|
1 020
+9%
|
1 097
+8%
|
|
| Equity | ||||||||
| Common Stock |
996
|
1 222
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
878
|
970
|
1 496
|
1 824
|
1 914
|
1 988
|
1 706
|
|
| Additional Paid In Capital |
72
|
179
|
3 407
|
3 737
|
4 024
|
4 333
|
4 585
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
103
|
495
|
834
|
|
| Other Equity |
6
|
13
|
11
|
8
|
9
|
5
|
37
|
|
| Total Equity |
197
N/A
|
418
+112%
|
1 922
+359%
|
1 920
0%
|
2 016
+5%
|
1 846
-8%
|
2 083
+13%
|
|
| Total Liabilities & Equity |
508
N/A
|
867
+71%
|
2 573
+197%
|
2 735
+6%
|
2 955
+8%
|
2 865
-3%
|
3 179
+11%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
519
|
519
|
541
|
557
|
569
|
554
|
535
|
|
Switch to:
Switch to:
See Also
Discover More
